Novartis fined $422.5M in marketing, kickback case
Thursday, September 30, 2010 - 17:28
in Mathematics & Economics
(AP) -- Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, federal officials announced Thursday.